Sam Michels informed the BBC: "We are pleased to be aware of that this dreadful drug has finally been recognised for the actual potential risks it poses", including that, "although we continue to plan to drive reclassification to Course A, moving to Course B is a substantial action forward".This Web-site is for informational functions only. Usually